Stock Information
AbbVie Inc (ABBV)
Ticker Symbol: ABBV
Exchange: NYSE
Sector: Biotechnology
Market Cap: $410,356.65 mil
Piotroski score: 9
PE Ratio: 92.8728
EPS (TTM): 2.3828
Revenue (TTM): $34.44 M
Dividend Yield: 3.124859%
ROE: 95.59%
Latest News
-
AbbVie Inc. (ABBV): Billionaire Ken Fisher Admires This Pharma Stock
Tue, Mar 17, 2026 8:18 PM
-
Big drugmakers must face US overcharge claims on medications for low-income patients
Tue, Mar 17, 2026 6:33 PM
-
AbbVie Slips Below 50-Day SMA: Buy, Sell or Hold the Stock?
Tue, Mar 17, 2026 3:42 PM
-
Alloy Therapeutics Enters Into Agreement to Advance Novel Antibody Discovery Platform
Tue, Mar 17, 2026 10:00 AM
-
Caribou Biosciences: Antlers Up For The Allogenic CAR-T Bet Trading At Cash Value
Tue, Mar 17, 2026 9:38 AM
-
AbbVie Partners With Alloy Therapeutics To Build Next-Gen Antibody Discovery Platform
Tue, Mar 17, 2026 6:07 AM
-
PJP: Healthcare Dashboard For March
Tue, Mar 17, 2026 5:12 AM
-
William Blair Asserts AbbVie Inc. (ABBV) Growth Prospects on Obesity Treatment Opportunities
Mon, Mar 16, 2026 9:11 PM
-
AbbVie’s Skin Quality Index Aims To Shape Aesthetics Growth Narrative
Mon, Mar 16, 2026 9:10 PM
-
Allergan Aesthetics Redefines Skin Quality Communication with Launch of Skin Quality Index
Mon, Mar 16, 2026 12:00 PM
Key Financials
Financial data not available